Jean-Jacques Kiladjian/LinkedIn
Apr 12, 2026, 14:18
Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared on LinkedIn:
“Thanks to the Malaysian Society of Haematology for the invitation to participate in the ‘Highlights of ASH’ in Asia-Pacific 2026.
Delighted to discuss the advances of interferon treatment in MPNs with Winnie Teo from National University of Singapore National University Cancer Institute, Singapore and Chew Lee Ping from Borneo.”
More posts featuring Jean Jacques Kiladjian on Hemostasis Today.
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Grateful to Be Connecting with so Many Families and Advocates at HFA 2026 in New Orleans
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA